Pei‐Min Hsieh

466 total citations
19 papers, 352 citations indexed

About

Pei‐Min Hsieh is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Pei‐Min Hsieh has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Pei‐Min Hsieh's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Pei‐Min Hsieh is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Pei‐Min Hsieh collaborates with scholars based in Taiwan, United States and Mexico. Pei‐Min Hsieh's co-authors include Yaw‐Sen Chen, Chih‐Wen Lin, Chia‐Chang Hsu, Chao‐Tien Hsu, Hung‐Yu Lin, Chung-Hsu Lai, Gin‐Ho Lo, Che‐Chung Yeh, Ching‐Shwun Lin and Guiting Lin and has published in prestigious journals such as PLoS ONE, Medicine and World Journal of Gastroenterology.

In The Last Decade

Pei‐Min Hsieh

18 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Min Hsieh Taiwan 11 137 112 103 79 73 19 352
Tomoki Ryu Japan 14 185 1.4× 104 0.9× 314 3.0× 157 2.0× 80 1.1× 53 525
Koichi Suto Japan 7 86 0.6× 168 1.5× 92 0.9× 158 2.0× 87 1.2× 12 323
Jiaping Zheng China 12 43 0.3× 44 0.4× 44 0.4× 104 1.3× 48 0.7× 34 360
Zusen Wang China 14 81 0.6× 86 0.8× 110 1.1× 71 0.9× 57 0.8× 37 440
Andrea Marcadis United States 11 50 0.4× 137 1.2× 26 0.3× 137 1.7× 44 0.6× 23 431
Songshan Chai China 10 37 0.3× 64 0.6× 27 0.3× 43 0.5× 48 0.7× 36 333
Yoichi Saitoh Japan 9 52 0.4× 156 1.4× 41 0.4× 202 2.6× 82 1.1× 14 334
Angélique Guillaudeau France 11 108 0.8× 66 0.6× 9 0.1× 52 0.7× 89 1.2× 18 397
Silvia González-Martínez Spain 9 40 0.3× 99 0.9× 12 0.1× 34 0.4× 43 0.6× 14 273

Countries citing papers authored by Pei‐Min Hsieh

Since Specialization
Citations

This map shows the geographic impact of Pei‐Min Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Min Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Min Hsieh more than expected).

Fields of papers citing papers by Pei‐Min Hsieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Min Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Min Hsieh. The network helps show where Pei‐Min Hsieh may publish in the future.

Co-authorship network of co-authors of Pei‐Min Hsieh

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Min Hsieh. A scholar is included among the top collaborators of Pei‐Min Hsieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Min Hsieh. Pei‐Min Hsieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hsiao, Po‐Jen, Kuang‐Chun Hu, Pei‐Min Hsieh, et al.. (2025). Significant predictors of clinical outcomes in metabolic associated fatty liver disease-related hepatocellular carcinoma following hepatectomy. Medicine. 104(28). e43248–e43248.
2.
Hsieh, Pei‐Min, Po‐Jen Hsiao, Yaw‐Sen Chen, et al.. (2023). Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis. The Kaohsiung Journal of Medical Sciences. 39(3). 302–310. 2 indexed citations
3.
Tsai, Ming‐Chao, Yaw‐Sen Chen, Pei‐Min Hsieh, et al.. (2022). NPRL2 down‐regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression. Hepatology Communications. 6(12). 3563–3577. 7 indexed citations
4.
Chen, Yaw‐Sen, Pei‐Min Hsieh, Hung‐Yu Lin, et al.. (2021). Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterology. 21(1). 220–220. 11 indexed citations
6.
Perng, Daw‐Shyong, Chao‐Ming Hung, Hung‐Yu Lin, et al.. (2021). Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection. BMC Cancer. 21(1). 828–828. 7 indexed citations
7.
Chen, Ping‐Hung, Jen‐Hao Yeh, Po‐Jen Hsiao, et al.. (2021). Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterology. 21(1). 418–418. 19 indexed citations
9.
Hsiao, Po‐Jen, Yaw‐Sen Chen, Chia‐Chang Hsu, et al.. (2019). Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma. Medicine. 98(25). e16074–e16074. 8 indexed citations
10.
Hsu, Chia‐Chang, Pei‐Min Hsieh, Yaw‐Sen Chen, et al.. (2019). Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection. Cancer Medicine. 8(7). 3453–3463. 22 indexed citations
11.
Lin, Chih‐Wen, Chih‐Wen Lin, Yaw‐Sen Chen, et al.. (2018). Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection. PLoS ONE. 13(9). e0202650–e0202650. 18 indexed citations
12.
Lin, Chih‐Wen, Chih‐Che Lin, Po‐Huang Lee, et al.. (2017). The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma. Oncotarget. 8(54). 91902–91913. 14 indexed citations
13.
Hsieh, Pei‐Min, et al.. (2012). Effect of thalidomide on the expression of vascular endothelial growth factor in a rat model of liver regeneration. Oncology Letters. 5(3). 852–856. 4 indexed citations
14.
Hsieh, Pei‐Min, et al.. (2012). Expression of aquaporins in rat liver regeneration. Scandinavian Journal of Gastroenterology. 47(6). 676–685. 10 indexed citations
16.
Hsieh, Pei‐Min, et al.. (2009). Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: Case reports and literature review. World Journal of Gastroenterology. 15(37). 4726–4726. 44 indexed citations
17.
Lin, Chih‐Wen, Chung-Hsu Lai, Chia‐Chang Hsu, et al.. (2009). Primary hepatic carcinoid tumor: a case report and review of the literature. Cases Journal. 2(1). 90–90. 68 indexed citations
18.
Liu, Cheng‐Hsien, Chih‐Kun Huang, Hsin‐Pao Chen, et al.. (2009). Retromammary Approach for Endoscopic Resection of Benign Breast Lesions. World Journal of Surgery. 33(12). 2572–2578. 20 indexed citations
19.
Lin, Guiting, et al.. (2003). Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia. British Journal of Urology. 92(6). 631–635. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026